1. Home
  2. MYGN vs AQST Comparison

MYGN vs AQST Comparison

Compare MYGN & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$5.44

Market Cap

523.7M

Sector

Health Care

ML Signal

N/A

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

N/A

Current Price

$3.48

Market Cap

529.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYGN
AQST
Founded
1991
2004
Country
United States
United States
Employees
2700
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
523.7M
529.4M
IPO Year
1996
2007

Fundamental Metrics

Financial Performance
Metric
MYGN
AQST
Price
$5.44
$3.48
Analyst Decision
Hold
Strong Buy
Analyst Count
9
9
Target Price
$5.90
★ $9.33
AVG Volume (30 Days)
1.7M
★ 2.3M
Earning Date
11-04-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $771,400,000.00
$67,430,000.00
Revenue This Year
N/A
$11.13
Revenue Next Year
N/A
$40.69
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 2.33
0.77
52 Week Low
$2.74
$2.94
52 Week High
$8.09
$6.74

Technical Indicators

Market Signals
Indicator
MYGN
AQST
Relative Strength Index (RSI) 46.99 36.68
Support Level $4.19 N/A
Resistance Level $5.52 $4.29
Average True Range (ATR) 0.30 0.23
MACD -0.13 0.02
Stochastic Oscillator 0.00 13.33

Price Performance

Historical Comparison
MYGN
AQST

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: